2024 SPEAKERS INCLUDE

 

Lois Ahn, Associate Director, PV Science, Alnylam Pharmaceuticals

Lois Ahn | Associate Director, PV Science | Alnylam Pharmaceuticals » speaking at Drug Safety USA

Vivek Ahuja, Senior Vice President, Global Delivery Excellence, Strategy & Growth, PV, Quality & Regulatory Service Lines, Eversana

Omar Aimer, Executive Committee member of ISoP; Founder of InnoVigilance, Innovigilance

Omar Aimer | Executive Committee member of ISoP; Founder of InnoVigilance | Innovigilance » speaking at Drug Safety USA

Anand Ananthakrishnan, Senior Director, Drug Safety and Pharmacovigilance, Blueprint Medicines

Anand Ananthakrishnan | Senior Director, Drug Safety and Pharmacovigilance | Blueprint Medicines » speaking at Drug Safety USA

Maria Anitan, Global Head of Pharmacovigilance and Drug Safety, Med Communications Inc

Maria Anitan | Global Head of Pharmacovigilance and Drug Safety | Med Communications Inc » speaking at Drug Safety USA

Felix Arellano, Senior Vice President, Global Head of Safety and Risk Management, Roche

Felix Arellano | Senior Vice President, Global Head of Safety and Risk Management | Roche » speaking at Drug Safety USA

Jamal Baig, Director, Pharmacovigilance, Multi Country Safety Head, Sanofi

Jamal Baig | Director, Pharmacovigilance, Multi Country Safety Head | Sanofi » speaking at Drug Safety USA

Khaudeja Bano, Vice President, Combination Product Quality, Amgen

Khaudeja Bano | Vice President, Combination Product Quality | Amgen » speaking at Drug Safety USA

Erika Barbarosie, Associate Director, Compliance, Gilead Sciences

Erika Barbarosie | Associate Director, Compliance | Gilead Sciences » speaking at Drug Safety USA

Chris Bone, Pharmacovigilance Scientist, Biogen

Chris Bone | Pharmacovigilance Scientist | Biogen » speaking at Drug Safety USA

Benjamin Brown, Executive Director, American Society of Pharmacovigilance

Benjamin Brown | Executive Director | American Society of Pharmacovigilance » speaking at Drug Safety USA

David T Chonzi, Independent Pharma Physician, Instil Bio

David T Chonzi | Independent Pharma Physician | Instil Bio » speaking at Drug Safety USA

Mugdha Chopra, Co-Founder and Director, AWINSA Life Sciences

Abimbola Cole, Scientific Director, Safety Evaluation & Risk Management (SERM), GSK

Abimbola Cole | Scientific Director, Safety Evaluation & Risk Management (SERM) | GSK » speaking at Drug Safety USA

Juan Daccach, Vice President, Global Product Safety, Merz Aesthetics

Juan Daccach | Vice President, Global Product Safety | Merz Aesthetics » speaking at Drug Safety USA

Saba Darvesh, Director - Global Safety Systems Owner, Vertex Pharmaceuticals

Saba Darvesh | Director - Global Safety Systems Owner | Vertex Pharmaceuticals » speaking at Drug Safety USA

Elena Davison, Executive Director, Pharmacovigilance Informatics, SMPA

Elena Davison | Executive Director, Pharmacovigilance Informatics | SMPA » speaking at Drug Safety USA

Abhay Dhingra, Associate Director of Pharmacovigilance Digital Innovation, Moderna, Inc.

Abhay Dhingra | Associate Director of Pharmacovigilance Digital Innovation | Moderna, Inc. » speaking at Drug Safety USA

Kal Elhoregy, Director, Global Risk Management & Pharmacovigilance Compliance, Global Patient Safety, Amneal Pharmaceuticals

Kal Elhoregy | Director, Global Risk Management & Pharmacovigilance Compliance, Global Patient Safety | Amneal Pharmaceuticals » speaking at Drug Safety USA

Katie Ellis Tupe, Senior Manager, US Patient Safety Operations, EMD Serono

Katie Ellis Tupe | Senior Manager, US Patient Safety Operations | EMD Serono » speaking at Drug Safety USA

Joann Evangelista, Head of US Patient Safety Operations & Innovations, Genentech, a member of the Roche group

Joann Evangelista | Head of US Patient Safety Operations & Innovations | Genentech, a member of the Roche group » speaking at Drug Safety USA

Serban Ghiorghiu, Chief Safety Officer, AstraZeneca

Serban Ghiorghiu | Chief Safety Officer | AstraZeneca » speaking at Drug Safety USA

Israel Gutierrez, Chief Medical Officer, TLR Therapeutics

Israel Gutierrez | Chief Medical Officer | TLR Therapeutics » speaking at Drug Safety USA

Bill Haddock, Head Of Safety, Ovid Therapeutics

Bill Haddock | Head Of Safety | Ovid Therapeutics » speaking at Drug Safety USA

Paul Hayashi, DILI Team Lead, Division of Hepatology & Nutrition, FDA

Paul Hayashi | DILI Team Lead, Division of Hepatology & Nutrition | FDA » speaking at Drug Safety USA

Ana-Claudia Ianos, Director, Safety Risk Lead, Pfizer Ltd

Ana-Claudia Ianos | Director, Safety Risk Lead | Pfizer Ltd » speaking at Drug Safety USA

Ajinkya Inamdar, Senior Director (Global Medical Safety Strategy), BioNTech SE

Ajinkya Inamdar | Senior Director (Global Medical Safety Strategy) | BioNTech SE » speaking at Drug Safety USA

Jijo James, Chief Medical Officer, Medical Devices, Johnson & Johnson

Jijo James | Chief Medical Officer, Medical Devices | Johnson & Johnson » speaking at Drug Safety USA

Vineet Kacker, Managing Director & Global Technical Head, APCER Life Sciences

Vineet Kacker | Managing Director & Global Technical Head | APCER Life Sciences » speaking at Drug Safety USA

Jennifer Kane, Sr. Director, Head of Pharmacovigilance, Entasis Therapeutics

Jennifer Kane | Sr. Director, Head of Pharmacovigilance | Entasis Therapeutics » speaking at Drug Safety USA

Mamiko Kasho, Executive Director, Eisai

Mamiko Kasho | Executive Director | Eisai » speaking at Drug Safety USA

Vikalp Khare, Director, US Head of Global Safety Data Management, GPV, Otsuka Pharmaceutical

Vikalp Khare | Director, US Head of Global Safety Data Management, GPV | Otsuka Pharmaceutical » speaking at Drug Safety USA

Ben kitchens, Associate Director, Medical Devices, Digital and Diagnostics Lead, Otsuka

Ben kitchens | Associate Director, Medical Devices, Digital and Diagnostics Lead | Otsuka » speaking at Drug Safety USA

Brian Kraemer, Social Media Director, Genentech, a member of the Roche group

Brian Kraemer | Social Media Director | Genentech, a member of the Roche group » speaking at Drug Safety USA

Geneviève Larouche, Global Director, Pharmacovigilance and Medical Information, Knight Therapeutics

Geneviève Larouche | Global Director, Pharmacovigilance and Medical Information | Knight Therapeutics » speaking at Drug Safety USA

Brooks Lowe, Associate Director, Pharmacovigilance Quality Assurance (PVQA), GSK

Han Ma, SVP, Chief Safety Officer, BeiGene

Han Ma | SVP, Chief Safety Officer | BeiGene » speaking at Drug Safety USA

Philisha Mack, Director of Drug Safety, Azurity Pharmaceuticals

Philisha Mack | Director of Drug Safety | Azurity Pharmaceuticals » speaking at Drug Safety USA

Bruno Mendez, VP global Head Medical and Pharmacovigilance Quality, Sanofi

Bruno Mendez | VP global Head Medical and Pharmacovigilance Quality | Sanofi » speaking at Drug Safety USA

Tarik Messaoud, Drug Safety Physician, Access Clinical Research

Tarik Messaoud | Drug Safety Physician | Access Clinical Research » speaking at Drug Safety USA

Sanjeev Miglani, Founder and Director, AWINSA Life Sciences

Madhu Mondal, Senior Director, Cerevel therapeutics

Madhu Mondal | Senior Director | Cerevel therapeutics » speaking at Drug Safety USA

Narayan Nair, Division Director for Division of Pharmacovigilance, Center for Biologics Evaluation and Research, U.S. Federal Drug Administration

Narayan Nair | Division Director for Division of Pharmacovigilance, Center for Biologics Evaluation and Research | U.S. Federal Drug Administration » speaking at Drug Safety USA

Jaylaxmi Nalawade, Director, Pharmacovigilance and REMS, Lupin

Jaylaxmi Nalawade | Director, Pharmacovigilance and REMS | Lupin » speaking at Drug Safety USA

Gerson Peltz, Senior Vice President of Patient Safety & Pharmacovigilance, Arcus Biosciences Inc

Gerson Peltz | Senior Vice President of Patient Safety & Pharmacovigilance | Arcus Biosciences Inc » speaking at Drug Safety USA

Jan Petracek, Chief Executive Officer, iVigee

Kamlesh Prabhu, Sr.Director Pharmacovigilance, Omega therapeutics

Kamlesh Prabhu | Sr.Director Pharmacovigilance | Omega therapeutics » speaking at Drug Safety USA

Alison Purdon, Director, US Patient Safety, Genentech

Arie Regev, Vice President, Medical Global Patient Safety, Lilly and Company

Sara Rogers, President, American Society of Pharmacovigilance

Ranjeeta Sinvhal, Executive Medical Director, Abbvie

Ranjeeta Sinvhal | Executive Medical Director | Abbvie » speaking at Drug Safety USA

Ira Solomon, Chief Safety Officer, Innovation, Johnson & Johnson

Ira Solomon | Chief Safety Officer, Innovation | Johnson & Johnson » speaking at Drug Safety USA

Heather Stein, Vice President, Head of Oncology Clinical Safety, gsk

Heather Stein | Vice President, Head of Oncology Clinical Safety | gsk » speaking at Drug Safety USA

Tarak Thakker, Director, Head of Safety Systems and Analytics, BeiGene

Tarak Thakker | Director, Head of Safety Systems and Analytics | BeiGene » speaking at Drug Safety USA

Danielle Thomas, Life Sciences Customer Consultant, Elsevier

Larry Thomas, Senior Director of Head Pharmacovigilance and Regulatory Affairs Audit Management, Bayer Pharma AG

Ujjval Trivedi, Global System Auditor, Bayer

Ujjval Trivedi | Global System Auditor | Bayer » speaking at Drug Safety USA

Thuy Truong, Director, PV Systems, Vertex Pharmaceuticals Inc.

Thuy Truong | Director, PV Systems | Vertex Pharmaceuticals Inc. » speaking at Drug Safety USA

Jose Vega, SVP, Chief Safety Officer, Moderna, Inc.

Sumit Verma, President, Clinical Safety and PV, Soterius, Inc.

Sumit Verma | President, Clinical Safety and PV | Soterius, Inc. » speaking at Drug Safety USA

Javier Waksman, Vice President, Head Of Global Drug Safety, Cerevel therapeutics

Javier Waksman | Vice President, Head Of Global Drug Safety | Cerevel therapeutics » speaking at Drug Safety USA

Suneet Walia, Chief Executive Officer, Soterius, Inc.

Suneet Walia | Chief Executive Officer | Soterius, Inc. » speaking at Drug Safety USA

Aman Wasan, Chief Executive Officer, ArisGlobal LLC

Susan Welsh MD, Senior Vice President, PV & Chief Safety Officer, Mirati Therapeutics

Susan Welsh MD | Senior Vice President, PV & Chief Safety Officer | Mirati Therapeutics » speaking at Drug Safety USA

Renata Yoshida, Head International Patient Safety - Latin America & Canada, Hoffman La Roche

Elena Yureneva, Executive Director, Head of Medical Safety and Risk Management, Alnylam Pharmaceuticals

Elena Yureneva | Executive Director, Head of Medical Safety and Risk Management | Alnylam Pharmaceuticals » speaking at Drug Safety USA

Dimitrios Zampatis, Global Program Safety Lead, Global Patient Safety, Sandoz

Dimitrios Zampatis | Global Program Safety Lead, Global Patient Safety | Sandoz » speaking at Drug Safety USA

Oleg Zvenigorodsky, Director, Medical Safety / Innovation Lead, Jazz Pharmaceuticals

Oleg Zvenigorodsky | Director, Medical Safety / Innovation Lead | Jazz Pharmaceuticals » speaking at Drug Safety USA
 

 

 

MORE TO BE ANNOUNCED

REGISTER TODAY

 

Get Involved At Drug Safety Congress Americas

 

For Sponsorship and Exhibition opportunities

Semen Sen
semen.sen@terrapinn.com
t/ + 646-619-1793

 

 

To Speak


Gina McHugh
gina.mchugh@terrapinn.com
t/ +1 646 619 1775

 

 

Marketing & Press Opportunities


Kaylie Brogan
kaylie.brogan@terrapinn.com
t/ +1 646 619 1785